The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus - Related systemic non-Hodgkin lymphoma

Cancer

Volumn 86, Issue 11, 1999, Pages 2391-2397

  Rossi, Giuseppe ^a,d   Donisi, Alessandra ^b   Casari, Salvatore ^b   Re, Alessandro ^a   Cadeo, Gianpiero ^c   Carosi, Giampiero ^b  

^a Sezione Ematologia   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Div Mal Infett   (Italy)

^d Spedali Civili   (Italy)

Author keywords

Chemotherapy; Human immunodeficiency virus; International Prognostic Index; Non Hodgkin lymphoma; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LIFE EXPECTANCY; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 0033458716     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991201)86:11<2391::AID-CNCR29>3.0.CO;2-0     Document Type: Article

References (22)

1. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984;311:565-70.
2. Lowenthal DA, Straus DJ, Campbell SW, Gold JW, Clarkson BD, Koziner B. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988;61:2325-37.
3. Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989;261:719-24.
4. Tirelli U, Spina M, Vaccher E, Errante D, Tavio M, Simonelli C, et al. Clinical evaluation of 451 patients with HIV related non-Hodgkin's lymphoma: experience of the Italian Cooperative Group on AIDS and Tumors (G.I.C.A.T.). Leuk Lymphoma 1995;20:91-6.
5. Gill PS, Levine AM, Krailo M, Rarick MU, Loureiro C, Deyton L, et al. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol 1987;5:1322-8.
6. Gisselbrecht C, Oksenhendler E, Tirelli U, Lepage E, Gabarre J, Farcet JP, et al. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med 1993;95:188-96.
7. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997;336:1641-8.
8. Levine AM, Sullivan-Halley J, Pike MC, Rarick MU, Loureiro C, Bernstein-Singer M, et al. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 1991;68:2466-72.
9. Straus DJ, Huang J, Testa MA, Levine AM, Kaplan LD. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142 - low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases. J Clin Oncol 1998;16:3601-06.
10. Roithman S, Toledano M, Tourani JM, Raphael M, Gentilini M, Gastaut JA, et al. HIV-associated non-Hodgkin's lymphoma: clinical characteristics and outcome. The experience of the French registry of HIV-associated tumors. Ann Oncol 1991;2:289-95.
11. Gabarre J, Raphael M, Lepage E, Schlaifer D, Martin A, Neidhardt EM, et al. Clinical relevance of histological subtypes in human immunodeficiency virus-related non Hodgkin's lymphomas. Blood 1998;92(Suppl 1):243a.
12. Vaccher E, Tirelli U, Spina M, Talamini R, Errante D, Simonelli C, et al. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single institute study of 96 patients. J Clin Oncol 1996;14:2217-23.
13. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-94.
14. Lopez Guillermo A, Montserrat E, Bosch F, Terol MJ, Campo E, Rozman C. Applicability of the International Index for Aggressive Lymphoma to patients with low-grade lymphoma. J Clin Oncol 1994;12:1343-8.
15. Ansell SM, Habermann TM, Kurtin PJ, Witzig TE, Chen MG, Li CY, et al. Verification of the predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. Blood 1996;88(Suppl 1):221a.
16. National Cancer Institute-sponsored study of classification of non-Hodgkin's lymphoma. Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49:2112-35.
17. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Classification. Cancer Res 1971;31:1860-1.
18. Miller AB, Hogestraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
19. Centers for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS adolescents and adults. MMWR 1993;41:1-18.
20. Miller TP, Dahlberg S, Weick JK, Files IC, Eyre HJ, Pendergrats KB, et al. Unfavorable Autore ultimo salvataggio Spedali Civili Autore histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study. J Clin Oncol 1990;8:1951-8.
21. Hagemeister FB, Khetan R, Allen P, McLaughlin P, Rodriguez MA, Swan F Jr., et al. Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas. Ann Oncol 1994;5(Suppl 2):41-6.
22. Navarro JT, Ribera JM, Oriol A, Vaquero M, Romeu J, Batlle M, et al. International Prognostic Index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP: a multivariate study of 46 patients. Haematologica 1998;83:508-13.